Selected data models

You must log in to select data models for download or further analysis.

70 Search results.
Relevance Rating New first Old first

Eligibility NCT00334295 Metastatic Endometrial Carcinoma - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 8 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion criteria
ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Endometrial Cancer NCT01210222 Pre-Study - GOG-0229L: Fast Fact Sheet for Protocol 0229L (Endometrium) - 3184152v1.0 - GOG-0229L: Fast Fact Sheet for Protocol 0229L (Endometrium)

- 9/17/21 - 1 form, 3 itemgroups, 88 items, 1 language
Itemgroups: Patient Information, Eligibility 1, Provide comments about this Fast Fact Sheet
GOG-0229L: Fast Fact Sheet for Protocol 0229L (Endometrium) AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9A223983-7B94-E221-E040-BB89AD437E30

Endometrial Cancer NCT00265759 Registration - ACOSOG-Z1031 OPEN Registration Worksheet - 3014513v1.0 - ACOSOG-Z1031 OPEN Registration Worksheet

- 9/17/21 - 1 form, 6 itemgroups, 45 items, 1 language
Itemgroups: Header Module, Demography Section, General Information, Inclusion Criteria, Exclusion Criteria, Treatment Arm
ACOSOG-Z1031 OPEN Registration Worksheet Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8036B060-D675-EB4B-E040-BB89AD434531

Endometrial Cancer NCT01225887 Pre-Study - GOG-0229K: Fast Fact Sheet for Protocol 0229-K (Endometrium) - 3183206v1.0 - GOG-0229K: Fast Fact Sheet for Protocol 0229-K (Endometrium)

- 9/17/21 - 1 form, 3 itemgroups, 91 items, 1 language
Itemgroups: Patient Information, Eligibility 1, Provide comments about this Fast Fact Sheet
GOG-0229K: Fast Fact Sheet for Protocol 0229-K (Endometrium) BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99D51BE9-A450-39B5-E040-BB89AD43255D

Endometrial Cancer NCT00265759 Registration - Z1031 Registration Worksheet Form - 2417050v1.0 - Z1031 Registration Worksheet Form

- 9/17/21 - 1 form, 9 itemgroups, 66 items, 1 language
Itemgroups: Header Module, Header, Patient Information, Correlative Studies and Specimen Banking , Inclusion Criteria, Exclusion Criteria, Eligibility/Performance Status, Clinical Stage, Primary Tumor Biopsy
Z1031 Registration Worksheet Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02F0FC02-607A-58B8-E044-0003BA3F9857

Eligibility Endometrial Cancer NCT01262040

- 12/6/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive; ODM derived from: https://clinicaltrials.gov/show/NCT01262040

Eligibility Lynch Syndrome NCT02494791

- 5/3/19 - 1 form, 1 itemgroup, 18 items, 1 language
Itemgroup: Criteria
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02494791

Eligibility Endometrial Carcinoma NCT02506816

- 3/28/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preoperative Olaparib Endometrial Carcinoma Study (POLEN); ODM derived from: https://clinicaltrials.gov/show/NCT02506816

Eligibility Cancer NCT00756847

- 11/10/17 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00756847

Endometrial Cancer Radiation Therapy NCT00807768 GOG-0249 - Quality of Life

- 7/14/17 - 1 form, 7 itemgroups, 60 items, 1 language
Itemgroups: PHYSICAL WELLBEING, FUNCTIONAL WELLBEING, Additional Concerns, FACT/GOG-NTX, FACIT Fatigue Scale, PROMIS Fatigue Short Form 1, Clinical Staff
GOG-0249 Quality of Life (QOL) Form Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Endometrial Cancer NCT00807768 Quality of Life - GOG-0249 Quality of Life (QOL) Form - 2786253v1.0

Endometrial Cancer Combination Chemotherapy NCT00063999 GOG-0209 - Quality of Life FACT-En

- 7/14/17 - 1 form, 3 itemgroups, 34 items, 1 language
Itemgroups: Physical Well-Being, Functional Well-Being, Additional Concerns
Endometrial Cancer NCT00063999 Quality of Life - FACT-En (Version 4), GOG-0209 - 2077672v3.0 FACT-En (Version 4), GOG-0209 Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer https://clinicaltrials.gov/ct2/show/NCT00063999

Registration Endometrial Cancer NCT00063999

- 7/29/15 - 1 form, 4 itemgroups, 27 items, 1 language
Itemgroups: HEADER MODULE, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, FOOTER MODULE
Registration Endometrial Cancer NCT00063999 Registration Form, GOG-0209, Form R Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B23EF80F-A3B1-0ED8-E034-0003BA12F5E7

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial